Tacrolimus Intrapatient Variability After Switching From Immediate or Prolonged-Release to Extended-Release Formulation, After an Organ Transplantation

Background and Purpose: Several formulations of tacrolimus are available, but evidence of the benefit of changing to the most recent formulations is lacking. Tacrolimus intra-patient variability (tacrolimus IPV) is an emerging risk factor associated with poor graft outcomes after solid organ transpl...

Descripción completa

Detalles Bibliográficos
Autores principales: Del Bello, Arnaud, Gaible, Clotilde, Longlune, Nathalie, Hebral, Anne-Laure, Esposito, Laure, Gandia, Peggy, Kamar, Nassim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8529208/
https://www.ncbi.nlm.nih.gov/pubmed/34690747
http://dx.doi.org/10.3389/fphar.2021.602764

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8529208/
https://www.ncbi.nlm.nih.gov/pubmed/34690747
http://dx.doi.org/10.3389/fphar.2021.602764

Ejemplares similares